What is the first‑line management of acute idiopathic unilateral lower motor neuron facial nerve palsy (Bell's palsy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Management of Bell's Palsy

Prescribe oral corticosteroids within 72 hours of symptom onset—prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days followed by a 5-day taper—as this is the only proven effective treatment that significantly improves facial nerve recovery. 1

Immediate Assessment and Diagnosis

  • Confirm the diagnosis through rapid onset of unilateral facial weakness involving the forehead (developing in <72 hours) without identifiable cause, ensuring no other cranial nerve involvement or central signs that would suggest stroke, tumor, or infection 1, 2

  • Do NOT order routine laboratory tests or imaging for typical presentations, as this delays treatment without improving outcomes 1, 3

  • Distinguish from stroke by documenting forehead involvement (peripheral lesion affects entire face including forehead, while central stroke spares forehead) and absence of limb weakness, speech difficulties, or other neurologic deficits 2

Corticosteroid Therapy (Cornerstone Treatment)

  • Initiate prednisolone 50 mg orally once daily for 10 days OR prednisone 60 mg orally once daily for 5 days followed by 5-day taper (10 mg decrements) 1, 3

  • Treatment MUST begin within 72 hours of symptom onset—initiating beyond this window provides no benefit 1, 3

  • Evidence demonstrates 83% recovery at 3 months with prednisolone versus 63.6% with placebo, and 94.4% recovery at 9 months versus 81.6% with placebo 1

  • For diabetic patients, corticosteroids remain strongly recommended despite temporary hyperglycemia risk—monitor capillary glucose every 2-4 hours during first few days and proactively adjust diabetes medications 1

Antiviral Therapy Considerations

  • Never prescribe antiviral monotherapy—it is completely ineffective and delays appropriate corticosteroid treatment 1, 3

  • May offer valacyclovir 1 g three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days in combination with corticosteroids within 72 hours, though added benefit is minimal (96.5% complete recovery versus 89.7% with steroids alone) 1, 4

  • The decision to add antivirals should acknowledge the small potential benefit against minimal risks 1

Eye Protection (Critical for Preventing Permanent Corneal Damage)

  • Implement immediately for all patients with impaired eye closure: 1

    • Lubricating ophthalmic drops every 1-2 hours while awake
    • Ophthalmic ointment at bedtime for sustained moisture retention
    • Eye taping or patching at night with careful instruction on proper technique to avoid corneal abrasion
    • Sunglasses outdoors for protection against wind and foreign particles
    • Moisture chambers using polyethylene covers for severe cases
  • Refer urgently to ophthalmology for severe impairment with complete inability to close the eye or any signs of corneal exposure (pain, redness, vision changes, foreign body sensation) 1

Therapies NOT Recommended

  • Physical therapy has no proven benefit over spontaneous recovery and should not be used as primary treatment 1, 5

  • Acupuncture is not recommended due to poor-quality evidence and indeterminate benefit-harm ratio 1

  • Surgical decompression is contraindicated except in rare specialized circumstances 1

Follow-Up and Referral Triggers

  • Schedule reassessment at 1-2 weeks to monitor recovery trajectory, reinforce eye protection, and identify early complications 1

  • Mandatory referral to facial nerve specialist at 3 months if facial recovery remains incomplete 1, 3

  • Immediate referral required for: 1

    • New or worsening neurologic findings at any point (suggests alternative diagnosis)
    • Development of ocular symptoms (corneal exposure risk)
    • Progressive weakness beyond 3 weeks (atypical for Bell's palsy)

Special Population Considerations

  • Children: Have better prognosis with higher spontaneous recovery rates (up to 94%), but corticosteroid benefit is less conclusive—involve caregivers in shared decision-making regarding treatment 1, 3

  • Pregnant women: Treat with oral corticosteroids within 72 hours using individualized risk-benefit assessment, as pregnancy increases Bell's palsy risk 1

Common Pitfalls to Avoid

  • Delaying corticosteroid initiation beyond 72 hours eliminates treatment effectiveness 1, 3

  • Prescribing antiviral monotherapy instead of corticosteroids wastes critical treatment window 1, 3

  • Failing to provide adequate eye protection instructions leads to preventable corneal damage 1

  • Missing atypical features (bilateral weakness, isolated branch paralysis, other cranial nerve involvement, gradual onset) that indicate alternative diagnoses requiring imaging 1, 2

  • Ordering unnecessary laboratory tests or imaging for typical presentations delays treatment 1, 3

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria and Exclusions for Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Facial Nerve Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Research

Physical therapy for Bell's palsy (idiopathic facial paralysis).

The Cochrane database of systematic reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.